Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2017-05-08 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2017
Transaction in Own Shares Classification · 100% confidence The document text is very short (262 characters) and describes a specific transaction: Novozymes buying back its own shares (2,455,809 shares for 675.4 million DKK) under a previously announced share repurchase program. This directly corresponds to the definition of 'Transaction in Own Shares' (POS). The final line, 'Læs hele meddelelsen i PDF fomat' (Read the entire announcement in PDF format), suggests this might be a brief announcement, but the core content is a definitive report of a share transaction, making POS the most specific fit over a general RPA or RNS.
2017-05-08 Danish
Transaction in Own Shares 2017
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes has purchased shares under a stock buyback program, detailing the number of shares and transaction value. This directly relates to the company repurchasing its own stock. The filing category 'Transaction in Own Shares' (POS) is the most appropriate fit for reporting share buybacks. The document is very short and mentions reading the full announcement in PDF format, which might suggest RPA, but the core content is a direct report of a share transaction, making POS the primary classification.
2017-05-08 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 100% confidence The document is a report detailing specific daily transactions under a company's stock buyback program, including tables of share counts, average prices, and transaction values. It explicitly mentions 'Transactions under Novozymes' stock buyback program' and provides detailed trading data as an appendix. This fits the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2017-05-08 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 100% confidence The document is a corporate announcement from Novozymes regarding transactions made under its share buyback program. It details the number of shares purchased, the average price, and the total transaction value, and includes an appendix with granular trade data. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2017-05-08 English
Director's Dealing 2017
Director's Dealing Classification · 99% confidence The document text is in Danish and its title translates to "Transactions by senior management and their closely associated persons". The content explicitly references Article 19 of EU Regulation No. 596/2014 (Market Abuse Regulation) and details the sale of shares by 'Novo A/S', which is closely associated with a CEO/Board member of Novozymes A/S. This type of mandatory disclosure regarding personal share transactions by directors and executives falls directly under the definition of Director's Dealing (DIRS). The document is a detailed report of these transactions, not just an announcement of a report.
2017-05-08 English
Regulatory Filings 2017
Regulatory Filings
2017-05-08 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.